CADTH Canadian Drug Expert Committee recommendation. indication : for the symptomatic treatment of lower limb spasticity (LLS) in pediatric patients two years of age and older. AbobotulinumtoxinA (Dysport therapeutic--Ipsen Biopharmaceuticals Canada, Inc.) :

Saved in:

Bibliographic Details
Online Access:	Full text
Corporate Author:	CADTH Canadian Drug Expert Committee (Author)
Format:	Electronic eBook
Language:	English
Published:	Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018
Edition:	Version: Final.
Series:	Common drug review clinical review report.
Subjects:	Muscle Spasticity > drug therapy. Child. Lower Extremity. Botulinum Toxins, Type A > therapeutic use. Cost-Benefit Analysis. Insurance, Health, Reimbursement. Children. Family members. Canada.

Internet

Full text